ADCs

May 09, 2025

ADCs in Lung Cancer Treatment: ENHERTU’s Rise, HER3 & TROP-2 Challenges, and What’s Next in the Pipeline

Oct 04, 2024

7 Companies at the Forefront of Trispecific Antibody Development

Mar 15, 2024

Unveiling the Potential of TROP-2 Inhibitors: A New Frontier in Cancer Treatment

Jun 02, 2023

Antibody-drug Conjugates in Oncology: An Overview of the Current and Future Treatment Landscape

Apr 28, 2023

Roche’s CD79b ADC POLIVY: Attempt to Change DLBCL Treatment Space

Nov 30, 2022

Antibody-Drug Conjugate: The Smart Biological Bomb

Mar 03, 2015

Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy

Newsletter/Whitepaper